Volume : 13, Issue : 10, October – 2026
Title:
CHALLENGES IN DESIGNING ANDA FOR PARENTERAL PRODUCTS
Authors :
Boorugu Meghana*, Ch. Sunitha
Abstract :
Quality by Design (QbD) is a systematic approach that focuses on understanding and controlling product quality through the integration of scientific principles, risk management, and regulatory requirements. This abstract provides a comprehensive overview of the application of QbD principles in the development of parenteral drug formulations, which are administered via injections, infusions, or implants.Employing Quality by Design (QbD) during the development of parenteral drug formulations yields substantial advantages as it facilitates a thorough comprehension of the interplay amongst formulation variables, process parameters, and critical quality attributes (CQAs). By employing a proactive and science-based approach, manufacturers can optimize product quality, reduce batch failures, and enhance patient safety and efficacy.The QbD approach in parenteral drug formulations involves several key elements. The first step is to identify and define the Critical Quality Attributes (CQAs) that are crucial to ensure the safety and effectiveness of the drug product. These attributes include parameters such as potency, purity, stability, and drug release profiles. Secondly, QbD encourages the establishment of a design space, which defines the acceptable ranges of formulation and process parameters that ensure product quality within the desired CQA specifications.Furthermore, QbD promotes a lifecycle approach, encompassing the entire product lifecycle from development to post-approval changes. This involves continuous process verification, ongoing monitoring of product performance, and the implementation of quality control strategies to ensure consistency and reliability.In conclusion, the application of QbD principles in parenteral drug formulations offers a robust and science-based approach to ensure product quality, safety, and efficacy. By leveraging these principles, manufacturers can optimize formulations, control critical parameters, and enhance process.
Cite This Article:
Please cite this article in press Boorugu Meghana et al., Challenges In Designing Anda For Parenteral Product.,. Indo Am. J. P. Sci, 2026; 13(10).
REFERENCES:
1. Augustine, E. F., Adams, H. R., and Mink, J. W. (2013). Clinical Trials in Rare Disease: Challenges and Opportunities.J.Child. Neurol.28 (9), 1142–1150. doi:10.1177/0883073813495959
2. Saha, P. (2020). EVOLUTION OF TOLBUTAMIDE IN THE TREATMENT OF DIABETES MELLITUS.Diabetes,2, 10.
3. Basile, A. O., Yahi, A., and Tatonetti, N. P. (2019). Artificial Intelligence for Drug Toxicity and Safety.Trends Pharmacol. Sci.40 (9), 624–635. doi:10.1016/j.tips.2019.07.005
4. Nyarko, R. O., Kumar, R., Sharma, S., & Chourasia, A. (2022). Ayushmann Roy, and Purabi Saha.”.Antibacterial Activity Of Herbal Plant-Tinospora Cordifolia And Catharnthus Roseus.
5. Bate, A., and Hobbiger, S. F. (2021). Artificial Intelligence, Real-World Automation and the Safety of Medicines.Drug Saf.44 (2), 125–132. doi:10.1007/s40264-020-01001-7
6. ZAIDI, S., MEHRA, R., & TYAGI, D. S. ROSHAN KUMAR ANUBHAV DUBEY.(2021). Effect of Kalahari Cactus Extract on Appetitte, Body Weight And Lipid Profile In Cafeteria Diet Induced Obesity In Experimental Animal.Annals of the Romanian Society for Cell Biology,25(6), 13976-13987.
7. Crisafulli, S., Ientile, V., L’Abbate, L., Fontana, A., Linguiti, C., Manna, S., et al. (2021). COVID-19 Patient Management in Outpatient Setting: A Population-Based Study from Southern Italy.Jcm11 (1), 51. doi:10.3390/jcm11010051
8. Nyarko, R. O., Awuchi, C. G., Kumar, R., Boateng, E., Kahwa,I., Boateng, P. O., … & Saha, P. (2022). Evaluation of Cafeteria Diet in Experimental Animal with Plant Extract of Calotropis procera for Obesity Parameter.Journal for Research in Applied Sciences and Biotechnology,1(3), 107-113.
9. Digital Therapeutics Alliance (2021). Understanding DTx: A New Category of Medicine. Available at:https://dtxalliance.org/understanding-dtx/. (Accessed January 30, 2022).
10. Pandey, M., Singh, A., Agnihotri, N., Kumar, R., Saha, P., Pandey, R. P., & Kumar, A. (2022). Clinical Pharmacology & Therapeutic uses of Diuretic Agents: A Review.Journal for Research in Applied Sciences and Biotechnology,1(3), 11-20.